Acera Surgical Restrata MiniMatrix Micronized Wound Management 200mg
In Stock: 1 Each
Express: Need it tomorrow? Order in next 2 hours 8 minutes and choose overnight shipping at checkout.
The item listed above is expired and may be used for educational, training, and non-clinical research purposes only. Any product information appearing below, including the product indication statement, pertains to an in-date item only.
Description
Acera Surgical Restrata MiniMatrix Micronized Wound Management
A micronized, dispersible form of Restrata, MiniMatrix may be applied to soft tissue areas with irregular or complex topography. Individual pieces of the micronized matrix are less than 3.15mm in diameter
Intended for use in the management of wounds, including
- Partial and full thickness wounds
- Draining wounds
- Pressure sores/ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds
- Surgical wounds (e.g., donor site/grafts, post-laser surgery, post-Mohs surgery, podiatric wounds, and dehisced wounds)
- Trauma wounds (e.g., abrasions, lacerations, partial-thickness burns, and skin tears)
Additional information
| Size | 1 |
|---|---|
| Arms | N/A |
| Manufacturer | |
| Unit | box of 1 |
- FDA Product Code: QSZ
- FDA Product Code Name: Absorbable Synthetic Wound Dressing
- GMDN Term Code: 64853
- GMDN Term Name: Synthetic wound matrix dressing
- GMDN Term Description: A sterile bioabsorbable device designed to be applied to hard-to-heal wounds (e.g., diabetic and venous insufficiency ulcers) or burns that involve the dermis, and that provides a matrix of structural synthetic fibres to facilitate the infiltration of native skin elements (e.g., fibroblasts, leukocytes, blood vessels) for skin regeneration; it may in addition be intended to facilitate regeneration of hard tissues such as bone (e.g., in cases of osteomyelitis) and may provide wound exudate absorbency. It does not contain biological materials. This is a single-use device.
